Advertisement

Mobile Banner
Mobile Banner
Mobile Banner
Loading...

Artivion, Inc.

AORTNYSE
Healthcare
Medical - Devices
$38.00
$-0.01(-0.01%)
U.S. Market is Open • 15:53

Artivion, Inc. Fundamental Analysis

Artivion, Inc. (AORT) shows weak financial fundamentals with a PE ratio of 185.07, profit margin of 2.21%, and ROE of 2.44%. The company generates $0.4B in annual revenue with moderate year-over-year growth of 9.75%.

Key Strengths

PEG Ratio0.97
Current Ratio2.99

Areas of Concern

ROE2.44%
Operating Margin6.85%
Cash Position3.56%
We analyze AORT's fundamental strength across five key dimensions.

The stock receives a Fundamental Health Score of 37.3/100 based on profitability, valuation, growth, and balance sheet metrics. The F grade reflects weak fundamentals and significant financial concerns.

Fundamental Health Score

F
37.3/100

We analyze AORT's fundamental strength across five key dimensions:

Efficiency Score

Weak

AORT struggles to generate sufficient returns from assets.

ROA > 10%
1.10%

Valuation Score

Moderate

AORT shows balanced valuation metrics.

PE < 25
185.07
PEG Ratio < 2
0.97

Growth Score

Excellent

AORT delivers strong and consistent growth momentum.

Revenue Growth > 5%
9.75%
EPS Growth > 10%
57.33%

Financial Health Score

Excellent

AORT maintains a strong and stable balance sheet.

Debt/Equity < 1
0.65
Current Ratio > 1
2.99

Profitability Score

Weak

AORT struggles to sustain strong margins.

ROE > 15%
244.04%
Net Margin ≥ 15%
2.21%
Positive Free Cash Flow
No

Key Financial Metrics

Is AORT Expensive or Cheap?

P/E Ratio

AORT trades at 185.07 times earnings. This suggests a premium valuation.

185.07

PEG Ratio

When adjusting for growth, AORT's PEG of 0.97 indicates potential undervaluation.

0.97

Price to Book

The market values Artivion, Inc. at 4.03 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.

4.03

EV/EBITDA

Enterprise value stands at 26.70 times EBITDA. This signals the market has high growth expectations.

26.70

How Well Does AORT Make Money?

Net Profit Margin

For every $100 in sales, Artivion, Inc. keeps $2.21 as profit after all expenses.

2.21%

Operating Margin

Core operations generate 6.85 in profit for every $100 in revenue, before interest and taxes.

6.85%

ROE

Management delivers $2.44 in profit for every $100 of shareholder equity.

2.44%

ROA

Artivion, Inc. generates $1.10 in profit for every $100 in assets, demonstrating efficient asset deployment.

1.10%

Following the Money - Real Cash Generation

Operating Cash Flow

Artivion, Inc. generates limited operating cash flow of $37.98M, signaling weaker underlying cash strength.

$37.98M

Free Cash Flow

Artivion, Inc. generates weak or negative free cash flow of $-907.45K, restricting financial flexibility.

$-907.45K

FCF Per Share

Each share generates $-0.02 in free cash annually.

$-0.02

FCF Yield

AORT converts -0.05% of its market value into free cash.

-0.05%

Financial Ratios Analysis

Valuation Ratios

P/E Ratio

Price to earnings ratio

185.07

vs 25 benchmark

PEG Ratio

Price/earnings to growth ratio

0.97

vs 25 benchmark

P/B Ratio

Price to book value ratio

4.03

vs 25 benchmark

P/S Ratio

Price to sales ratio

4.08

vs 25 benchmark

Financial Health

Debt/Equity

Total debt to shareholders' equity

0.65

vs 25 benchmark

Current Ratio

Current assets to current liabilities

2.99

vs 25 benchmark

Efficiency Ratios

ROE

Return on equity percentage

0.02

vs 25 benchmark

ROA

Return on assets percentage

0.01

vs 25 benchmark

ROCE

Return on capital employed

0.04

vs 25 benchmark

How AORT Stacks Against Its Sector Peers

MetricAORT ValueSector AveragePerformance
P/E Ratio185.0729.43 Worse (Expensive)
ROE2.44%800.00% Weak
Net Margin2.21%-20145.00% (disorted) Weak
Debt/Equity0.650.30 Weak (High Leverage)
Current Ratio2.994.64 Strong Liquidity
ROA1.10%-17936.00% (disorted) Weak

AORT outperforms its industry in 1 out of 6 key metrics, but lagging in P/E Ratio.

Historical Growth Performance

5-Year Growth Trajectory

This section reviews Artivion, Inc.'s 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.

Revenue CAGR

25.28%

Industry Style: Defensive, Growth, Innovation

High Growth

EPS CAGR

-791.74%

Industry Style: Defensive, Growth, Innovation

Declining

FCF CAGR

25.13%

Industry Style: Defensive, Growth, Innovation

High Growth

Fundamental Analysis FAQ